Abdul Razak (@drabdulrazak_md) 's Twitter Profile
Abdul Razak

@drabdulrazak_md

Neonatologist Pursuing PhD @MonashUni, Fellow @MonashChildrens, SoME Editor @EBNEO, #RCTs, #SRMA, #NeoEBM, #Celltherapies #NeoOutcomes

ID: 1126396422507646976

calendar_today09-05-2019 08:00:09

2,2K Tweet

1,1K Followers

241 Following

Atul Malhotra (@atul_monash) 's Twitter Profile Photo
Atul Malhotra
@atul_monash

a month ago

Preprint (not peer-reviewed) of our CORDSaFe study by Lindsay Zhou et al is out. Feasibility & Safety of Autologous Cord Blood Derived Cell Administration in Extremely Preterm Infants: papers.ssrn.com/sol3/papers.cf… Look forward to comments, #neoTwitter! Evidence-Based Neo ESPR The Incubator Podcast

Preprint (not peer-reviewed) of our CORDSaFe study by <a href="/LindsayDZhou/">Lindsay Zhou</a> et al is out. Feasibility &amp; Safety of Autologous Cord Blood Derived Cell Administration in Extremely Preterm Infants: papers.ssrn.com/sol3/papers.cf… Look forward to comments, #neoTwitter! <a href="/EBNEO/">Evidence-Based Neo</a> <a href="/ESPR_ESN/">ESPR</a> <a href="/nicupodcast/">The Incubator Podcast</a>
Atul Malhotra (@atul_monash) 's Twitter Profile Photo
Atul Malhotra
@atul_monash

a month ago

Some of our Newborn Cell Therapies team members marking the start of another world first study Monash Children's. Allo Trial - Safety & Feasibility of Allogeneic Cord Blood-Derived Cell Therapy in Preterm Infants with Severe Brain Injury anzctr.org.au/Trial/Registra… Watch this space!

Some of our <a href="/Neo_CellTherapy/">Newborn Cell Therapies</a> team members marking the start of another world first study <a href="/MonashChildrens/">Monash Children's</a>. Allo Trial - Safety &amp; Feasibility of Allogeneic Cord Blood-Derived Cell Therapy in Preterm Infants with Severe Brain Injury anzctr.org.au/Trial/Registra… Watch this space!